What is DocGo's trading securities in marketable securities?

DocGo (DCGO) reported trading securities in marketable securities of $0 in Q1 2026.

How has DocGo's trading securities in marketable securities changed year-over-year?

DocGo's trading securities in marketable securities decreased by 100.0% year-over-year, from $5M to $0.

DocGo DCGO Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

ARD

Ardent Health PartnersARDT

——

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's trading securities in marketable securities?: DocGo (DCGO) reported trading securities in marketable securities of $0 in Q1 2026.
How has DocGo's trading securities in marketable securities changed year-over-year?: DocGo's trading securities in marketable securities decreased by 100.0% year-over-year, from $5M to $0.